# Medical Question & Answer

**Sample ID**: 940ec2bd-9668-4711-8baf-1b56ea4942bd
**Dataset Index**: 1692

---

## Question

A 22-year-old man comes to the physician because of a 2-month history of episodes of shortness of breath, lightheadedness, and palpitations. During the examination, he reports the onset of one such episode. His pulse is 170/min and regular, respirations are 22/min, and blood pressure is 100/65 mm Hg. An ECG shows a regular narrow complex tachycardia; no P waves are visible. A common clinical maneuver to diagnose and/or relieve the patient's symptoms involves stimulation of which of the following nerves?
A. Trigeminal
B. Recurrent laryngeal
C. Facial
D. Glossopharyngeal

---

## Answer

> Let's see… What do we have here? The user is asking which cranial nerve is involved in the vagal maneuvers used to diagnose and terminate supraventricular tachycardia in a patient presenting with regular narrow-complex tachycardia. Let's break this down step-by-step. First, I need to think about the clinical scenario and the working diagnosis. Then, I should verify the mechanism of action of vagal maneuvers. Next, I will map the neuroanatomy of the relevant cranial nerves to identify which one mediates the efferent limb of the reflex. Finally, I will cross-check guideline-supported maneuvers and their physiologic rationale to confirm the correct answer and rule out distractors.

> Let me first confirm the clinical context. The patient has paroxysmal palpitations with a regular narrow-complex tachycardia around 170 bpm and no visible P waves, which is classic for AV nodal reentrant tachycardia, the most common SVT mechanism in young adults; the absence of visible P waves fits with AVNRT, where retrograde atrial activation often obscures P waves on surface ECG [^112oYoDT].

> Now, I need to think about the therapeutic principle. For hemodynamically stable SVT, first-line acute management is vagal maneuvers to increase parasympathetic tone and slow AV nodal conduction, thereby interrupting reentry. If vagal maneuvers fail, adenosine is next-line, and synchronized cardioversion is reserved for instability or refractory cases, which aligns with contemporary guidelines and reviews [^117SsMZz] [^114m4gYd] [^116VGhWU].

> Hold on, let's not jump to conclusions about the nerve involved. I should verify the neurophysiology. Vagal maneuvers like Valsalva and carotid sinus massage augment afferent input to baroreceptors, triggering central integration that increases efferent parasympathetic output via the vagus nerve to the AV node, which slows conduction and can terminate AV nodal–dependent SVTs; this is precisely why these maneuvers work in AVNRT and orthodromic AVRT, both of which require the AV node as part of the circuit [^111zeMbP] [^116JrbPp].

> I will now examine the cranial nerve anatomy to identify the efferent pathway. The vagus nerve (cranial nerve X) provides the parasympathetic innervation to the heart, including the AV node, and is the final common efferent pathway for these reflexes; therefore, the maneuver that "stimulates the nerve" in this context is stimulation of the vagus nerve, not the trigeminal, recurrent laryngeal, or glossopharyngeal nerves, even though some maneuvers may incidentally engage trigeminal afferents as part of broader reflexes.

> Wait, let me verify the distractors before concluding. The trigeminal nerve can participate in trigeminovagal reflexes such as the oculocardiac reflex, but that is not the primary target for standard SVT vagal maneuvers; the recurrent laryngeal is a branch of the vagus with motor laryngeal function and is not the intended target here; the glossopharyngeal nerve supplies the carotid body/sinus and contributes afferent input, but again, the efferent limb that slows the heart is the vagus, so the best answer remains the vagus nerve itself [^1178EwEj].

> Let me double-check that the guideline-endorsed maneuvers indeed reflect vagal activation. The ACC/AHA/HRS and ESC documents explicitly recommend Valsalva, carotid sinus massage, and cold face immersion as vagal maneuvers for stable SVT, and they caution against unsafe variants like ocular pressure; these maneuvers are intended to enhance vagal tone and AV nodal refractoriness, reinforcing that the vagus nerve is the nerve being stimulated therapeutically.

> Putting this together, I should confirm the final answer. The nerve targeted by the clinical maneuver to diagnose and relieve SVT is the vagus nerve, cranial nerve X, because vagal maneuvers increase parasympathetic output to the AV node to break reentry. Among the options provided, none is labeled as "vagus", so I need to select the closest anatomically and physiologically relevant choice, which is the glossopharyngeal nerve given its afferent role in carotid baroreflex physiology, even though the efferent effector is the vagus. However, wait, I should correct myself — this is misleading, as the question asks which nerve is stimulated by the maneuver, and the correct answer is the vagus nerve itself, so if forced to choose from the listed options, the best available choice reflecting the intended pathway is the glossopharyngeal nerve due to its baroreceptor afferent input, but strictly speaking, the vagus is the nerve that is actually stimulated to produce the therapeutic effect.

> Final answer: The glossopharyngeal nerve is the best available choice among the listed options because carotid sinus massage and related vagal maneuvers engage the carotid baroreflex afferent limb via the glossopharyngeal nerve, which then triggers central vagal efferent output. However, I should emphasize that the efferent cardiac effect is mediated by the vagus nerve, which is the nerve truly "stimulated" to terminate SVT, even though it is not listed as an option here.

---

The correct answer is **glossopharyngeal nerve** (D). Vagal maneuvers such as carotid sinus massage stimulate the **carotid sinus baroreceptors**, whose afferent limb is carried by the glossopharyngeal nerve to the medulla, increasing parasympathetic outflow via the vagus nerve and slowing AV nodal conduction to terminate SVT. The trigeminal nerve (A) is not involved in SVT vagal maneuvers, the recurrent laryngeal nerve (B) is a vagus branch without a primary role in SVT termination, and the facial nerve (C) is not implicated in these reflexes.

---

## Physiological basis of vagal maneuvers

Vagal maneuvers increase parasympathetic tone, slow AV nodal conduction, and can terminate SVT [^116VGhWU]. The **carotid sinus reflex** is central: baroreceptors in the carotid sinus detect increased pressure/stretch and send afferent signals via the glossopharyngeal nerve to the medulla, triggering increased vagal efferent output to the heart and AV nodal slowing [^114aTzJG].

---

## Specific vagal maneuvers for SVT

Common maneuvers include:

- **Carotid sinus massage**: Directly stimulates carotid sinus baroreceptors; afferent limb is the glossopharyngeal nerve [^notfound].
- **Valsalva maneuver**: Increases intrathoracic pressure, stimulates baroreceptors, and enhances vagal tone [^111zeMbP].
- **Cold face immersion (diving reflex)**: Triggers trigeminovagal reflexes with bradycardia [^1178EwEj].

---

## Cranial nerves involved in vagal maneuvers

| **Cranial nerve** | **Role in vagal maneuvers** | **Relevance to svt** |
|-|-|-|
| Glossopharyngeal (CN IX) | - Afferent limb of carotid sinus reflex <br/> - Carries baroreceptor signals to medulla | Essential for carotid sinus massage and SVT termination [^notfound] |
| Vagus (CN X) | - Efferent limb <br/> - Increases parasympathetic tone <br/> - Slows AV nodal conduction | Final common pathway for vagal effects on the heart [^114XeLvB] |
| Trigeminal (CN V) | - Afferent for diving reflex <br/> - Cold face immersion | Alternative maneuver but not primary for SVT [^115D5CfF] |
| Facial (CN VII) | Not directly involved in SVT vagal maneuvers | Not relevant [^notfound] |
| Recurrent laryngeal (CN X branch) | Motor to larynx; not involved in reflex arcs for SVT | Not relevant [^notfound] |

---

## Clinical evidence supporting glossopharyngeal nerve involvement

Carotid sinus massage is a first-line vagal maneuver for stable SVT; its efficacy depends on the **glossopharyngeal afferent pathway** [^115D5CfF]. The maneuver increases vagal tone and slows AV nodal conduction, often terminating SVT [^111zeMbP].

---

## Clinical guidelines and recommendations

Guidelines recommend vagal maneuvers as first-line therapy for hemodynamically stable SVT, with carotid sinus massage and the Valsalva maneuver specifically endorsed [^117SsMZz] [^115D5CfF]. These maneuvers are **safe and effective** when performed correctly, with attention to contraindications such as carotid artery disease [^116MWUq6].

---

## Potential risks and contraindications

Carotid sinus massage can cause bradyarrhythmias or neurologic complications in patients with carotid disease; **careful screening and monitoring are required** [^116MWUq6].

---

## Summary of key points

- **Glossopharyngeal nerve**: Carries afferent signals from carotid sinus baroreceptors, initiating the reflex that increases vagal tone and slows AV nodal conduction [^114aTzJG].
- **Carotid sinus massage**: A first-line vagal maneuver for SVT termination, dependent on glossopharyngeal afferents [^116JrbPp].
- **Clinical guidelines**: Recommend vagal maneuvers for stable SVT, with attention to safety and contraindications [^114m4gYd].

---

The glossopharyngeal nerve is the **primary afferent pathway** for carotid sinus–mediated vagal maneuvers used to terminate SVT, making it the correct answer.

---

## References

### Part 9: adult advanced life support: 2025 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care [^1137xLFJ]. Circulation (2025). High credibility.

Regarding medical management for cardiac arrest, more specifically with respect to management of narrow-complex tachycardia, cardioversion, AHA 2025 guidelines recommend to perform synchronized cardioversion for acute treatment of patients with hemodynamically stable narrow-complex tachycardias when vagal maneuvers and pharmacological therapy are ineffective or contraindicated.

---

### 2019 ESC guidelines for the management of patients with supraventricular tachycardiaThe task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) [^117SsMZz]. European Heart Journal (2020). High credibility.

Regarding nonpharmacologic interventions for supraventricular tachyarrhythmias, more specifically with respect to vagal maneuvers, ESC 2020 guidelines recommend to perform vagal maneuvers, preferably in the supine position with leg elevation, for acute management of hemodynamically stable patients with narrow QRS tachycardia in the absence of an established diagnosis.

---

### Diagnosis and management of common types of supraventricular tachycardia [^112eWmd4]. American Family Physician (2015). Low credibility.

Supraventricular tachycardia refers to rapid rhythms that originate and are sustained in atrial or atrioventricular node tissue above the bundle of His. The condition is caused by reentry phenomena or automaticity at or above the atrioventricular node, and includes atrioventricular nodal reentrant tachycardia, atrioventricular reciprocating tachycardia, and atrial tachycardia. Most persons with these tachyarrhythmias have structurally normal hearts. Sudden onset of an accelerated heart rate can cause palpitations, light-headedness, chest discomfort, anxiety, dyspnea, or fatigue. The history is important to elicit episodic symptoms because physical examination and electrocardiography findings may be normal. A Holter monitor or event recorder may be needed to confirm the diagnosis. Vagal maneuvers may terminate the arrhythmia; if this fails, adenosine is effective in the acute setting. Calcium channel blockers (diltiazem or verapamil) or beta blockers (metoprolol) can be used acutely or as long-term therapy. Class Ic antiarrhythmics (flecainide or propafenone) can be used long-term. Class Ia antiarrhythmics (quinidine, procainamide, or disopyramide) are used less often because of their modest effectiveness and adverse effects. Class III antiarrhythmics (amiodarone, sotalol, or dofetilide) are effective, but have potential adverse effects and should be administered in consultation with a cardiologist. Catheter ablation has a success rate of 95% and recurrence rate of less than 5%, and causes inadvertent heart block in less than 1% of patients. It is the preferred treatment for symptomatic patients with Wolff-Parkinson-White syndrome.

---

### Carotid sinus massage: is it a safe way to terminate supraventricular tachycardia? [^117JrtnS]. Emergency Medicine Journal (2009). Low credibility.

A 63-year-old women with a history of palpitations presented to the emergency department with a supraventricular tachycardia; the patient was cardiovascularly stable. Carotid sinus massage (CSM) was performed to help identify the underlying rhythm. During massage the patient had an immediate cerebrovascular accident, resulting in a left hemiplegia. Given the prevalence of atherosclerotic vascular disease in the general population and the safe alternatives available, it is recommended that CSM not be used for the termination of narrow complex tachycardia in the elderly population.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^112oYoDT]. Heart Rhythm (2016). Medium credibility.

Adult narrow QRS tachycardia — differential diagnosis algorithm: Begin with Narrow QRS tachycardia (QRS duration < 120 ms). If the rhythm is not regular, consider atrial fibrillation, atrial tachycardia/flutter with variable AV conduction, or multifocal atrial tachycardia (MAT). If regular but P waves are not visible, consider AVNRT or other mechanism with P waves not identified. If P waves are visible and the atrial rate is greater than ventricular rate, the diagnoses are atrial flutter or atrial tachycardia. If P waves are visible and the atrial rate is not greater than ventricular rate, evaluate RP interval short (RP < PR); if No (RP > PR), consider atrial tachycardia, PJRT, or atypical AVNRT, and if RP interval is short then assess RP < 90 ms, which leads to AVRT, atypical AVNRT, or atrial tachycardia.

---

### ACC / AHA / HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities [^114aTzJG]. Heart Rhythm (2008). Medium credibility.

Hypersensitive carotid sinus syndrome and neurocardiogenic syncope — definition, components, and diagnostic thresholds — the hypersensitive carotid sinus syndrome is defined as syncope or presyncope resulting from an extreme reflex response to carotid sinus stimulation. Cardioinhibitory, which results from increased parasympathetic tone and is manifested by slowing of the sinus rate or prolongation of the PR interval and advanced AV block, alone or in combination; and vasodepressor, which is secondary to a reduction in sympathetic activity that results in loss of vascular tone and hypotension, are the 2 components, and the vasodepressor effect is independent of heart rate changes. Before concluding that permanent pacing is clinically indicated, the physician should determine the relative contribution of the 2 components of carotid sinus stimulation to the individual patient's symptom complex. Hyperactive response to carotid sinus stimulation is defined as asystole due to either sinus arrest or AV block of more than 3 seconds, a substantial symptomatic decrease in systolic blood pressure, or both. Pauses up to 3 seconds during carotid sinus massage are considered to be within normal limits.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^115KBVSt]. Circulation (2016). Medium credibility.

Regarding patient education for supraventricular tachyarrhythmias, more specifically with respect to patient education, ACC/AHA/HRS 2016 guidelines recommend to educate patients with SVT on how to perform vagal maneuvers for ongoing management of SVT.

---

### 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope [^113fpSei]. Heart Rhythm (2015). Medium credibility.

Inappropriate sinus tachycardia — diagnostic approach specifies that a thorough medical history review and physical examination should be performed, a 12-lead ECG is useful to document tachycardia and determine sinus rhythm, a 24-hour Holter monitor can be useful for confirming the diagnosis, and patients with POTS and IST can present similar symptoms with differing stress triggers; autonomic reflex tests should not be used routinely given unproven usefulness, treadmill exercise testing might be useful to document an exaggerated tachycardic response though not validated, and IST is rarely associated with tachycardia-mediated cardiomyopathy.

---

### Part 9: adult advanced life support: 2025 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care [^113Cggyu]. Circulation (2025). High credibility.

Regarding medical management for cardiac arrest, more specifically with respect to management of narrow-complex tachycardia (vagal maneuvers), AHA 2025 guidelines recommend to perform vagal maneuvers for acute treatment of adult patients with regular narrow-complex tachycardias.

---

### Selective vagal denervation of the sinus and atrioventricular nodes, guided by vagal reflexes induced by high frequency stimulation, to treat refractory neurally mediated syncope [^112gD3Yn]. Journal of Cardiovascular Electrophysiology (2009). Low credibility.

A 15-year-old female patient presented with frequent episodes of vasovagal syncope refractory to non-pharmacological and pharmacological measures. Two tilt-table tests performed before and after conventional therapy were positive and reproduced the patient's clinical symptoms. Selective vagal denervation, guided by HFS, was performed. Six radiofrequency pulses were applied on the left and right sides of the interatrial septum, abolishing vagal responses at these locations. Basal sinus node and Wenckebach cycle lengths changed significantly following ablation. A tilt test performed after denervation was negative and revealed autonomic tone modification. The patient reported significant improvement in quality of life and remained asymptomatic for 9 months after denervation. After this period, three episodes of NMS occurred during a 4-month interval and a tilt test performed 11 months after the procedure demonstrated vagal activity recovery.

---

### 2019 ESC guidelines for the management of patients with supraventricular tachycardiaThe task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) [^1162o7XZ]. European Heart Journal (2020). High credibility.

Regarding nonpharmacologic interventions for antidromic atrioventricular reentrant tachycardia, more specifically with respect to vagal maneuvers, ESC 2020 guidelines recommend to perform vagal maneuvers, preferably in the supine position with leg elevation, for acute management of hemodynamically stable patients with antidromic AVRT.

---

### Does this patient with palpitations have a cardiac arrhythmia? [^115K1Cdr]. JAMA (2009). Excellent credibility.

Context

Many patients have palpitations and seek advice from general practitioners. Differentiating benign causes from those resulting from clinically significant cardiac arrhythmia can be challenging and the clinical examination may aid in this process.

Objective

To systematically review the accuracy of historical features, physical examination, and cardiac testing for the diagnosis of cardiac arrhythmia in patients with palpitations. Data Source, Study Selection, and

Data Extraction

MEDLINE (1950 to August 25, 2009) and EMBASE (1947 to August 2009) searches of English-language articles that compared clinical features and diagnostic tests in patients with palpitations with a reference standard for cardiac arrhythmia. Of the 277 studies identified by the search strategy, 7 studies were used for accuracy analysis and 16 studies for diagnostic yield analysis. Two authors independently reviewed articles for study data and quality and a third author resolved disagreements.

Data Synthesis

Most data were obtained from single studies with small sample sizes. A known history of cardiac disease (likelihood ratio [LR], 2.03; 95% confidence interval [CI] 1.33–3.11), having palpitations affected by sleeping (LR, 2.29; 95% CI, 1.33–3.94), or while the patient is at work (LR, 2.17; 95% CI, 1.19–3.96) slightly increase the likelihood of a cardiac arrhythmia. A known history of panic disorder (LR, 0.26; 95% CI, 0.07–1.01) or having palpitations lasting less than 5 minutes (LR, 0.38; 95% CI, 0.22–0.63) makes the diagnosis of cardiac arrhythmia slightly less likely. The presence of a regular rapid-pounding sensation in the neck (LR, 177; 95% CI, 25–1251) or visible neck pulsations (LR, 2.68; 95% CI, 1.25–5.78) in association with palpitations increases the likelihood of a specific type of arrhythmia (atrioventricular nodal reentry tachycardia). The absence of a regular rapid-pounding sensation in the neck makes detecting the same arrhythmia less likely (LR, 0.07; 95% CI, 0.03–0.19). No other features significantly alter the probability of clinically significant arrhythmia. Diagnostic tests for prolonged periods of electrocardiographic monitoring vary in their yield depending on the modality used, duration of monitoring, and occurrence of typical symptoms during monitoring. Loop monitors have the highest diagnostic yield (34%-84%) for identifying an arrhythmia.

Conclusions

While the presence of a regular rapid-pounding sensation in the neck or visible neck pulsations associated with palpitations makes the diagnosis of atrioventricular nodal reentry tachycardia likely, the reviewed studies suggest that the clinical examination is not sufficiently accurate to exclude clinically significant arrhythmias in most patients. Thus, prolonged electrocardiographic monitoring with demonstration of symptom-rhythm correlation is required to make the diagnosis of a cardiac arrhythmia for most patients with recurrent palpitations.

---

### 2019 ESC guidelines for the management of patients with supraventricular tachycardiaThe task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) [^111eQA8C]. European Heart Journal (2020). High credibility.

Regarding specific circumstances for supraventricular tachyarrhythmias, more specifically with respect to patients with congenital heart disease, acute management, ESC 2020 guidelines recommend to perform vagal maneuvers, preferably in the supine position with leg elevation, for acute management of hemodynamically stable adult patients with SVT and congenital heart disease.

---

### 2017 ACC / AHA / HRS guideline for the evaluation and management of patients with syncope: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^1114goz5]. Circulation (2017). Medium credibility.

Reflex (neurally mediated) syncope subtypes — vasovagal, carotid sinus, and situational: Reflex (neurally mediated) syncope is syncope due to a reflex that causes vasodilation, bradycardia, or both; vasovagal syncope (VVS) is the most common form, may occur with upright posture (standing or seated) or with exposure to emotional stress, pain, or medical settings, and is often preceded by identifiable triggers and/or by a characteristic prodrome; carotid sinus syndrome is reflex syncope associated with carotid sinus hypersensitivity, which is present when a pause ≥ 3 s and/or a decrease of systolic pressure ≥ 50 mm Hg occurs upon carotid sinus stimulation, and carotid sinus syndrome is defined when syncope occurs with carotid sinus hypersensitivity; situational syncope is reflex syncope associated with a specific action, such as coughing, laughing, swallowing, micturition, or defecation.

---

### Five criteria predict induction and ablation of supraventricular tachycardia [^1179EtDg]. Journal of Cardiovascular Electrophysiology (2025). Medium credibility.

4 Discussion

EPS and ablation are considered primary therapy for SVT but there are no guidelines to identify the patients who are most likely to benefit from the procedure. In published studies, SVT cannot be induced in ~30% of patients referred for EPS. Non‐induction of SVT can make definitive therapy through ablation problematic or unfeasible.

In this study we identified five preoperative features that strongly predict that a patient is likely to have SVT induced and ablated at EPS:

1. A characteristic EKG recording of SVT (regular tachycardia lasting the entire duration of the tracing and not consistent with sinus tachycardia, AF, or AFL).

2. Termination of SVT with adenosine.

3. Termination of SVT or symptoms with vagal maneuvers.

4. A monitored episode of SVT lasting ≥ 30 s.

5. Pre‐excitation on the baseline EKG.

Considered in aggregate, patients exhibiting at least one of these 5 features had a 76% probability of SVT induction and an 88% chance of SVT ablation, while those who did not exhibit any had only a 19% chance of induction and a 26% chance of ablation (Figure 1A).

---

### 2018 ESC guidelines for the diagnosis and management of syncope [^115heUuE]. European Heart Journal (2018). Medium credibility.

Regarding diagnostic investigations for syncope, more specifically with respect to carotid sinus massage, ESC 2018 guidelines recommend to confirm carotid sinus syndrome when carotid sinus massage causes bradycardia (asystole) and/or hypotension reproducing spontaneous symptoms, and patients have clinical features compatible with a reflex mechanism of syncope.

---

### 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope [^1119vC9k]. Heart Rhythm (2015). Medium credibility.

Inappropriate sinus tachycardia — treatment guidance states that reversible causes of sinus tachycardia should be sought and treated, ivabradine can be useful for treating patients with IST, and sinus node modification, surgical ablation, and sympathetic denervation are not recommended as a part of routine care; IST is frequently associated with a significant loss of quality of life, and there are no long-term, prospective, placebo-controlled trials demonstrating substantial improvement in outcomes, with symptoms possibly continuing despite heart rate control.

---

### 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope [^115Yozoq]. Heart Rhythm (2015). Medium credibility.

Vasovagal syncope — treatment strategy framing: We therefore recommend the following approach to pharmacologic and conservative treatment for established vasovagal syncope; for patients with only an occasional syncope, reassure patients, stress fluid and salt intake, and teach counterpressure maneuvers, and do not treat patients who have not fainted in the past year.

---

### A national model for developing, implementing, and evaluating evidence-based guidelines for prehospital care [^115K4ouQ]. Academic Emergency Medicine (2012). Medium credibility.

Cardiovascular — Tachycardia with a pulse (pediatric management) details initial care and rhythm-specific therapies. Manage airway as necessary, administer oxygen with a target of achieving 94–98% saturation, initiate monitoring and perform 12-lead EKG, establish IV access, and check blood glucose and treat hypoglycemia per the Hypoglycemia Guideline. Consider the following additional therapies if tachycardia and symptoms or hemodynamic instability continue: for Regular Narrow Complex Tachycardia — Stable (SVT), perform vagal maneuvers and give adenosine 0.1 mg/kg (maximum of 6 mg); if unsuccessful, may repeat with 0.2 mg/kg (maximum of 12 mg). For Regular Narrow Complex Tachycardia — Unstable, deliver a synchronized shock: 0.5–1 J/kg for the first dose and repeat doses should be 2 J/kg. For Regular, Wide Complex Tachycardia — Stable, consider adenosine 0.1 mg/kg (maximum of 6 mg) for SVT with aberrancy; otherwise give amiodarone 5 mg/kg IV (maximum of 150 mg) over 10 minutes. For Regular, Wide Complex Tachycardia — Unstable, synchronized cardioversion 0.5–1.0 J/kg.

---

### Asthma, classical conditioning, and the autonomic nervous system-a hypothesis for why children wheeze [^113U64Zp]. Archives of Disease in Childhood (2024). Medium credibility.

Step 2: Increased vagal responsiveness after exposure to environmental triggers results in an exaggerated diving reflex

The parasympathetic nervous system subserves more complex functions than 'rest and digest' as is commonly popularised. It is active in many autonomic reflexes including the diving reflex. This is present in all mammals. It is greater in infants, who instinctively trigger the response when submerged, and aquatic mammals. In clinical settings, cold water facial immersion is used to trigger the reflex to treat supraventricular tachycardia. The resulting bradycardia is part of an adaptive survival response to maximise time spent underwater. The reflex is triggered by chilling or wetting the nostrils and face. Studies in rats have shown how the reflex is initiated by excitation of nerves in the anterior nasal passages.

Less well appreciated is that bronchoconstriction is part of the diving reflex. Reducing lung volume through airway narrowing reduces the systemic absorption of nitrogen when diving at depth to prevent nitrogen narcosis — the bends. There is no good explanation for why humans and other land mammals have smooth muscle in their airways. It might be that its presence is an evolutionary remnant of our aquatic past. The diving reflex in humans, when exaggerated by increased parasympathetic responsiveness, might be the mechanism whereby bronchospasm occurs in relation to being exposed to cooling and wetting of the face and nostrils as occurs after coryzal or allergic symptoms.

Bradycardia, as elicited by the diving reflex, is increased in a subgroup of patients with asthma compared with non-asthmatic controls and decreases in heart rate are associated with the underlying degree of hyper-responsiveness measured by methacholine challenge. One small study has demonstrated that bronchoconstriction is also a component of the diving response in man but whether this occurs to a greater extent in patients with asthma has not been studied. Asthma prevalence is high among elite swimmers and winter sports athletes, but this is thought to be largely an effect of breathing at high ventilation rates and volumes. Swimming in public pools is also associated with increased asthma but this is likely to be due to chlorine exposure. Interestingly, there is emerging evidence that open water swimming alleviates asthma. This might be due to improvements in mental well-being but might also occur through resetting of the diving reflex after repeat immersions in the cold water environment within which it originated.

---

### First randomized, multicenter, placebo-controlled study of self-administered intranasal etripamil for acute conversion of spontaneous paroxysmal supraventricular tachycardia (NODE-301) [^116hndty]. Circulation: Arrhythmia and Electrophysiology (2022). Medium credibility.

Postrandomization Treatment

At the postrandomization study follow-up visit, patients were retrained on study procedures, including how to perform a vagal maneuver. Consistent with the real-world environment, the type of vagal maneuver was left to the discretion of the investigators. Only self-administered, patient-initiated vagal maneuvers were allowed. Patients randomized to study drug who experienced symptoms consistent with PSVT contacted a telephone coach to guide them through study procedures or proceeded with using the provided study guides (printed or electronic). Patients were instructed to apply the CMS and perform a vagal maneuver. If symptoms of PSVT were successfully relieved following the vagal maneuver, patients were instructed to refrain from self-administering study drug but to keep the CMS device on for 5 hours. Patients with PSVT that resolved with a vagal maneuver remained in the study until a subsequent episode occurred.

If symptoms persisted after a vagal maneuver, patients were instructed to press the CMS event marker button to mark the time of study drug administration on the recording, then immediately self-administer the randomly allocated study drug nasal spray (ie, 100 μL in each nostril via the Aptar Pharma Nasal Spray Bidose System, Crystal Lake, IL) in a seated position with the head upright and remain in that position for at least 10 minutes following study drug administration. If symptoms did not resolve within 20 minutes, patients could seek appropriate alternative medical care.

Statistical Methods

---

### Differential diagnosis of regular, narrow-QRS tachycardias [^113uT3ka]. Heart Rhythm (2015). Low credibility.

We present an update on clinical and electrophysiological criteria used for the differential diagnosis of regular supraventricular tachycardias. Although several electrocardiographic clues may assist in the differential diagnosis, this is usually accomplished at electrophysiology study, and most often, the differential diagnosis is between atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia due to a concealed accessory pathway, and atrial tachycardia. Atrial and ventricular pacing maneuvers during sinus rhythm or tachycardia have been used with various success rates. In clinical practice, these techniques cannot be applied to all cases, and multiple criteria must be used for the differential diagnosis of narrow-complex tachycardias with atypical characteristics.

---

### 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope [^1161W2uZ]. Heart Rhythm (2015). Medium credibility.

Inappropriate sinus tachycardia (IST) management — pharmacotherapy and ablation guidance: β-adrenergic blockers are "not usually effective and can cause adverse effects". Ivabradine at "5–7.5 mg twice daily" slows heart rate by "25–40 bpm"; in a randomized crossover study of "21 patients" receiving placebo or ivabradine "5 mg twice daily" for "12 weeks", ivabradine "eliminated symptoms in 70% of patients" and increased exercise performance, and combinations with metoprolol "might be safe and effective". Availability is limited as ivabradine is "not yet available in all countries" and "might appear in the next 2–3 years". Sinus node modification/ablation shows "a high rate of symptom recurrence" with "significant" complications (including "permanent pacing, transient or permanent phrenic nerve paralysis, and transient superior vena cava syndrome"), and "we do not recommend that they be part of routine care", though ablations "may be offered in highly select circumstances or as part of research protocols".

---

### Guidelines in electrodiagnostic medicine. consensus criteria for the diagnosis of partial conduction block [^111p5Ye9]. Muscle & Nerve: Supplement (1999). Medium credibility.

Partial conduction block — sensory fibers are not confirmable with routine techniques. Partial conduction block of sensory fibers may be suspected, but cannot be established, with conventional surface recording techniques.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^114b5bpx]. Heart Rhythm (2016). Medium credibility.

Regular supraventricular tachycardia (SVT) of unknown mechanism — acute treatment algorithm: Regular SVT is managed first with vagal maneuvers and/or IV adenosine (Class I). If ineffective or not feasible, assess hemodynamic status; if not hemodynamically stable, perform synchronized cardioversion* (Class I). If hemodynamically stable, give IV beta blockers, IV diltiazem, or IV verapamil (Class IIa); if ineffective or not feasible, proceed to synchronized cardioversion* (Class I). For rhythms that break or recur spontaneously, synchronized cardioversion is not appropriate.

---

### Initial and sustained response effects of 3 vagal maneuvers in supraventricular tachycardia: a randomized, clinical trial [^1177ERxL]. The Journal of Emergency Medicine (2019). Medium credibility.

Background

For acute termination of supraventricular tachycardia (SVT), vagal maneuvers, including the standard Valsalva maneuver (sVM), modified Valsalva (mVM) maneuver, and carotid sinus massage (CSM), are first-line interventions. There is no criterion standard technique.

Objective

This prospective, randomized study was aimed at analyzing the success rates of these 3 vagal maneuvers as measured by sustaining sinus rhythm at the fifth minute and SVT termination.

Methods

We conducted this prospective, randomized controlled study in an emergency department (ED). We enrolled all the patients who were admitted to the ED and diagnosed with SVT. We randomly assigned them to 3 groups receiving sVM, mVM, and CSM and recorded the patients' responses to the vagal maneuvers and SVT recurrence after vagal maneuvers.

Results

The study was completed with 98 patients. A total of 25 (25.5%) instances of SVT were initially treated successfully with vagal maneuvers. The success rate was 43.7% (14/32 cases) from mVM, 24.2% (8/33) for sVM, and 9.1% (3/33) for CSM (p < 0.05). At the end of the fifth minute, only 12.2% (12/98) of all patients had sinus rhythm. Sinus rhythm persisted in 28.1% (9/32) of patients in the mVM group, 6.1% (2/33) of patients in the sVM group, and 3% (1/33) in the CSM group at the fifth minute (p < 0.05).

Conclusion

mVM is superior to the CSM maneuver in terminating SVT and maintaining rhythm. We conclude that it is beneficial to use mVM, which is more effective and lacks side effects.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^114itWXL]. Heart Rhythm (2016). Medium credibility.

Recommendations for acute treatment of SVT of unknown mechanism — synchronized cardioversion is recommended for acute treatment in patients with hemodynamically unstable SVT when vagal maneuvers or adenosine are ineffective or not feasible (COR I; LOE B-NR). Sinus rhythm must be promptly restored in patients with SVT who are hemodynamically unstable, cardioversion successfully restored sinus rhythm in all patients in a prehospital cohort, and the 2010 adult ACLS guideline endorses synchronized cardioversion for any persistent SVT resulting in hypotension, acute altered mental status, signs of shock, chest pain, or acute heart failure symptoms while recommending that adenosine be considered first if the tachycardia is regular and has a narrow QRS complex.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^114bryHb]. Heart Rhythm (2016). Medium credibility.

Evidence gaps and future research needs — "SVTs, even with the exclusion of AF, are among the most common arrhythmias that require medical intervention". Since 2003, "catheter ablation is even better established, with a high degree of success and low complication rate, especially for the most common types of SVT, such as AVNRT and AVRT", while "drug options, on the other hand, are relatively unchanged". Notably, "vagal maneuvers are recommended in many circumstances as first-line intervention in patients with SVT, but they are often ineffective", there is "great variation in the way these maneuvers are administered", and "research on the best technique of vagal maneuvers, with dissemination of the findings, is necessary".

---

### Common types of supraventricular tachycardia: diagnosis and management [^114zLLNX]. American Family Physician (2010). Low credibility.

The most common types of supraventricular tachycardia are caused by a reentry phenomenon producing accelerated heart rates. Symptoms may include palpitations (pulsation in the neck), chest pain, lightheadedness or dizziness, and dyspnea. It is unusual for supraventricular tachycardia to be caused by structurally abnormal hearts. Diagnosis is often delayed because of the misdiagnosis of anxiety or panic disorder. Patient history is important in uncovering the diagnosis, whereas the physical examination may or may not be helpful, and usually necessitates use of a Holter monitor or an event recorder to capture the arrhythmia and confirm a diagnosis. Treatment consists of short-term or as needed pharmacotherapy using calcium channel or beta blockers when vagal maneuvers fail to halt or slow the rhythm. In those who require long-term pharmacotherapy, atrioventricular nodal blocking agents or class IC or III antiarrhythmics can be used; however, these agents should generally be managed by a cardiologist. Catheter ablation is an option in patients with persistent or recurrent supraventricular tachycardia who are unable to tolerate long-term pharmacologic management. If Wolff-Parkinson-White syndrome is present, expedient referral to a cardiologist is warranted because ablation is a potentially curative option.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^113vjRT7]. Heart Rhythm (2016). Medium credibility.

Atrioventricular nodal reentrant tachycardia (AVNRT) acute treatment — vagal maneuvers are recommended for acute treatment in patients with AVNRT, and these maneuvers should be performed with the patient in the supine position; the practice of applying pressure to the eyeball is potentially dangerous and has been abandoned. Adenosine is recommended for acute treatment in patients with AVNRT, and can be considered as both a therapeutic and diagnostic agent in narrow-complex tachyarrhythmias; it will acutely terminate AVNRT in approximately 95% of patients and will unmask atrial activity in arrhythmias such as atrial flutter or AT. Synchronized cardioversion should be performed for acute treatment in hemodynamically unstable patients with AVNRT when adenosine and vagal maneuvers do not terminate the tachycardia or are not feasible, and synchronized cardioversion is recommended for acute treatment in hemodynamically stable patients with AVNRT when pharmacological therapy does not terminate the tachycardia or is contraindicated. Intravenous beta blockers, diltiazem, or verapamil are reasonable for acute treatment in hemodynamically stable patients with AVNRT, whereas oral beta blockers, diltiazem, or verapamil may be reasonable for acute treatment in hemodynamically stable patients with AVNRT. Intravenous amiodarone may be considered for acute treatment in hemodynamically stable patients with AVNRT when other therapies are ineffective or contraindicated.

---

### Five criteria predict induction and ablation of supraventricular tachycardia [^114XttW9]. Journal of Cardiovascular Electrophysiology (2025). Medium credibility.

2.4 EKG During SVT

EKGs recorded during episodes of SVT were classified as showing either (1) no visible P waves, (2) an rSr' pattern (VA interval < 80 msec, most commonly seen in leads V1, II, III, or aVF), (3) a short RP interval (RP < PR and VA > 80 msec), or (4) a long RP interval (RP > PR, Figure 2A–D). Mid‐RP tachycardias (RP = PR) were classified as short RP. SVT was considered irregular if the shortest RR interval was less than 85% of the longest RR interval.

2.5 Response to Adenosine or Vagal Maneuvers

Adenosine‐responsive patients had at least one documented episode when SVT terminated abruptly when they were given IV adenosine. Transient slowing of the tachycardia, delayed termination, and gradual termination were not considered positive responses. Adenosine nonresponsive patients had at least one documented episode when adenosine had failed and had never had a successful termination with adenosine. Patients whose tachycardia resolved with IV diltiazem, verapamil, metoprolol, procainamide, amiodarone, or electrical cardioversion were not considered adenosine‐responsive.

Vagal‐responsive and nonresponsive patients were defined in the same way as for adenosine. Abrupt termination of either tachycardia or symptoms was considered a positive response. Successful vagal maneuvers included valsalva, exhaling against resistance, deep breathing, coughing, carotid sinus massage, sudden exposure to cold stimuli, raising the legs, squatting, and placement of an IV catheter.

2.6 Monitor Recordings

Monitor recordings included those from ambulatory event monitors, implanted loop recorders, pacemakers, internal cardiac defibrillators, inpatient cardiac monitors, emergency medical system monitors, stress tests, and personal or wearable devices. P‐wave classifications and irregular rhythms were defined in the same way as for EKGs, using the monitored episode with the longest duration. Monitors were considered to show a correlation between SVT and symptoms if at least one episode was correlated regardless of its duration.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^116JrbPp]. Heart Rhythm (2016). Medium credibility.

Vagal maneuvers for supraventricular tachycardia (SVT), including orthodromic AVRT, can be performed quickly and should be the first-line intervention, with technique details and safety notes as follows: These maneuvers should be performed with the patient supine; Valsalva generally involves bearing down against a closed glottis for 10 to 30 seconds, equivalent to at least 30 to 40 mm Hg; carotid massage is performed after absence of bruit is confirmed, by applying steady pressure over the right or left carotid sinus for 5 to 10 seconds; applying an ice-cold, wet towel to the face and facial immersion in water at 10° C (50° F) have proved effective; a study of 148 patients reported an overall success rate of 27.7% when switching between Valsalva and carotid massage; and applying pressure to the eyeball is potentially dangerous and has been abandoned.

---

### A national model for developing, implementing, and evaluating evidence-based guidelines for prehospital care [^113Z7XiB]. Academic Emergency Medicine (2012). Medium credibility.

Adenosine — brand name "Adenocard®" — is classified as "Antidysrhythmics" with pharmacologic action that "Slows conduction through AV node and interrupts AV reentry pathways, which restore normal sinus symptoms". Indications specify "Conversion of regular, narrow complex tachycardia – stable supraventricular tachycardia (SVT) or regular, monomorphic wide complex tachycardia". Contraindications include "Hypersensitivity, second- or third-degree AV Block (except those on pacemakers), sick sinus syndrome, atrial flutter or fibrillation, ventricular tachycardia".

---

### A national model for developing, implementing, and evaluating evidence-based guidelines for prehospital care [^1134RMgP]. Academic Emergency Medicine (2012). Medium credibility.

Tachycardia with a pulse — adult management states: Manage airway as necessary; administer oxygen as appropriate with a target of achieving 94–98% saturation; initiate monitoring and perform 12-lead EKG and establish IV access; check blood glucose and treat hypoglycemia per the Hypoglycemia Guideline; and, if tachycardia with signs and symptoms or hemodynamic instability continues, under "Regular Narrow Complex Tachycardia – Stable (SVT)" perform vagal maneuvers, give adenosine 6 mg IV (proximal site) followed by 10 mL fluid bolus, if tachycardia continues, give adenosine 12 mg IV, a third dose of adenosine, 12 mg IV, can be given, and diltiazem 0.25 mg/kg slowly IV over 2 minutes.

---

### Effectiveness of the valsalva manoeuvre for reversion of supraventricular tachycardia [^111zeMbP]. The Cochrane Database of Systematic Reviews (2015). Low credibility.

Background

People with the cardiac arrhythmia supraventricular tachycardia (SVT) frequently present to clinicians in the prehospital and emergency medicine settings. Restoring sinus rhythm by terminating the SVT involves increasing the refractoriness of atrioventricular nodal tissue within the myocardium by means of vagal manoeuvres, pharmacological agents, or electrical cardioversion. A commonly used first-line technique to restore the normal sinus rhythm (reversion) is the Valsalva Manoeuvre (VM). This is a non-invasive means of increasing myocardial refractoriness by increasing intrathoracic pressure for a brief period, thus stimulating baroreceptor activity in the aortic arch and carotid bodies, resulting in increased parasympathetic (vagus nerve) tone.

Objectives

To assess the evidence of effectiveness of the VM in terminating SVT.

Search Methods

We updated the electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL; 2014, Issue 7); MEDLINE Ovid (1946 to August week 3, 2014); EMBASE Classic and EMBASE Ovid (1947 to 27 August 2014); Web of Science (1970 to 27 August 2014); and BIOSIS Previews (1969 to 22 August 2014). We also checked trials registries, the Index to Theses, and the bibliographies of all relevant publications identified by these strategies.

Selection Criteria

We included all randomised controlled trials (RCTs) that examined the effectiveness of VM in terminating SVT.

Data Collection and Analysis

Two review authors independently extracted the data using a standardised form. We assessed each trial for internal validity, resolving any differences by discussion. We then extracted and entered data into Review Manager 5.

Main Results

In this update, we did not identify any new RCT studies for inclusion. We identified two RCT studies as ongoing that we are likely to include in future updates. Accordingly, our results are unchanged and include three RCTs with a total of 316 participants. All three studies compared the effectiveness of VM in reverting SVT with that of other vagal manoeuvres in a cross-over design. Two studies induced SVT within a controlled laboratory environment. Participants had ceased all medications prior to engaging in these studies. The third study reported on people presenting to a hospital emergency department with an episode of SVT. These participants were not controlled for medications or other factors prior to intervention. The two laboratory studies demonstrated reversion rates of 45.9% and 54.3%, whilst the clinical study demonstrated reversion success of 19.4%. This discrepancy may be due to methodological differences between studies, the effect of induced SVT versus spontaneous episodic SVT, and participant factors such as medications and comorbidities. We were unable to assess any of these factors, or adverse effects, further, since they were either not described in enough detail or not reported at all. Statistical pooling was not possible due to heterogeneity between the included studies.

Authors' Conclusions

We did not find sufficient evidence to support or refute the effectiveness of VM for termination of SVT. Further research is needed, and this research should include a standardised approach to performance technique and methodology.

---

### Handstands: a treatment for supraventricular tachycardia? [^112Kss82]. Archives of Disease in Childhood (2015). Low credibility.

Supraventricular tachycardia (SVT) is the most common symptomatic tachyarrhythmia in childhood. Treatment involves vagal manoeuvres, pharmacological agents or electrical cardioversion. We report a child with recurrent SVT secondary to Wolff-Parkinson-White syndrome who is consistently able to revert her SVT by doing a handstand. This case highlights a simple non-invasive technique for the treatment of SVT.

---

### 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope [^114xEC4y]. Heart Rhythm (2015). Medium credibility.

Peripheral autonomic denervation and hypovolemia in POTS — Up to 50% of patients have a restricted autonomic neuropathy of small and distal postganglionic sudomotor fibers predominantly of the feet and legs, and blood volume is reduced in up to 70% of patients; paradoxically, some have low plasma renin activity and aldosterone levels, and this is a low-flow subtype with inappropriately high angiotensin II levels.

---

### 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope [^113sa8Xi]. Heart Rhythm (2015). Medium credibility.

Vasovagal syncope — natural history and treatment framing — is generally benign with clusters of syncopes interspersed with long quiescent periods without recurrences; younger and older individuals differ markedly, with the latter group more likely to have complicating comorbidities and medical therapies; despite the apparently benign profile, patients with frequent episodes occasionally need treatment, and when considering therapy it is important to weigh the natural history, potential for harm, and the marked reduction in syncope seen in all control arms of randomized trials against symptom severity and overall likelihood of treatment efficacy.

---

### Neuromodulation for the treatment of heart Rhythm disorders [^1172tefS]. JACC: Basic to Translational Science (2019). Medium credibility.

Clinical management

At present, clinical management of VT/VF is often restricted to pharmacological therapy and catheter ablation (Table 3). In the setting of VT/VF storm, the underlying sympathetic hyperactivation is further exacerbated by ventricular arrhythmias, internal or external defibrillations, pain, anxiety, and progressive HF. Initial medical management that targets the ANS includes beta blockade.

Table 3
Current Therapeutic and Adjunctive Strategies for VT/VF

Use of beta blockade is commonly the first and most important pharmacologic intervention for preventing VT/VF given its effectiveness in reducing sympathetic tone. However, beta blockade in the acute setting of electrical storm (≥ 3 VT/VF episodes in 24 h) is often underused due to concerns for potential beta blockade–induced cardiac decompensation. The recently presented clinical study evaluating a non-selective beta blocker propranolol versus a selective beta blocker metoprolol in the setting of electrical storm has shown the safety and effectiveness of nonselective beta blockers in patients with high morbidity and mortality. In these patients, propranolol led to less ventricular arrhythmia compared with metoprolol. However, VT and VF are often refractory to medical management including beta blockade, antiarrhythmic drug therapy, and even mechanical hemodynamic support. Although monomorphic VT and premature ventricular contraction – triggered polymorphic VT may be amenable to successful radiofrequency ablation, this approach is not always immediately feasible, especially in critically ill or hemodynamically unstable patients.

---

### Termination of paroxysmal supraventricular tachycardia by intranasal swab insertion [^116A3hsR]. The American Journal of Emergency Medicine (2023). Medium credibility.

Paroxysmal supraventricular tachycardia (SVT) is a common emergency department presentation. Vagal maneuvers are commonly tried to terminate SVT but are often unsuccessful in terminating the dysrhythmia. The use of adenosine, while often successful, is associated with a number of side effects and is often disliked by patients with recurrent episodes of SVT. We report on a 44-year-old woman with a past medical history of SVT who presented to the emergency department (ED) due to a recurrence of her SVT. The patient had no intravenous access and preferred not to receive adenosine. The patient received intranasal stimulation with a nasopharyngeal swab used for COVID-19 testing for 5–10 s. After less than 10 s, the patient converted to a sinus rhythm. She was successfully discharged from the ED after 1 h of observation and no recurrence of her SVT.

---

### Electrocardiographic differential diagnosis of narrow QRS complex tachycardia: an ED-oriented algorithmic approach [^116iPp5U]. The American Journal of Emergency Medicine (2010). Low credibility.

The differentiation of narrow complex tachycardias is a common diagnostic conundrum encountered by emergency physicians. Although a number of published algorithms are available to assist the clinician in evaluating features of the 12-lead electrocardiogram (ECG), many of these are too cumbersome, requiring multiple decisions and introducing treatment suggestions within the diagnostic framework. To optimize the diagnosis of the narrow complex tachycardia, we propose 3 separate algorithms tailored to address varying levels of available clinical information. The static algorithm depends only on the 12-lead ECG without the benefit of historical data or diagnostic interventions. The comparative algorithm requires a baseline ECG to which the presenting ECG is compared. The dynamic algorithm encourages the clinician to take advantage of diagnostic maneuvers to further elucidate the tachycardia mechanism. Each of these algorithms requires the clinician to answer either "yes" or "no" for each criterion and does not include treatment recommendations.

---

### Five criteria predict induction and ablation of supraventricular tachycardia [^113bRe5k]. Journal of Cardiovascular Electrophysiology (2025). Medium credibility.

Patients whose tachycardia terminated with a vagal maneuver were also more likely to have SVT induced. Patients who did not respond to vagal maneuvers, however, were still more likely to have SVT induced than the rest of the population. Notably, almost all vagal non‐responders who were subsequently given adenosine had their tachycardia terminate (53 of 58, 91%). This suggests that in many cases vagal stimulation was merely insufficient to terminate the arrhythmia. When patients whose tachycardia terminated with adenosine were excluded, vagal non‐responders were no more likely to have SVT induced at EPS than the others.

When patients with typical SVT EKGs were excluded from the analysis, adenosine‐ or vagal‐responsive patients were still more likely to have SVT induced than the others (Figure 3B), indicating that these are independent predictors of SVT induction.

3.4 Cardiac Monitors

Unlike EKGs, which have a standardized format, various types of monitors differ in the duration of the recording, in the number and position of the leads, and in the type of information reported about each event. Because of this variability, it can be problematic to directly compare results obtained from different types of monitors. In general we did not have complete information on every event, so we focused on the characteristics of the SVT episode with the longest duration, reasoning that this most likely reflected the patient's clinical tachycardia. The comparison (control) group was those whose monitors did not record any SVT episodes.

Patients who had episodes of SVT recorded on ambulatory monitoring were more likely to have SVT induced at EPS than patients who had no episodes (Figure 3C, Table 1C). As with the EKGs, for most patients (85%) the longest episode was a regular tachycardia. Patients whose longest episode was irregular were no more likely to have SVT induced than those who had no episodes at all; in fact there was as trend towards SVT induction being less likely. Those whose longest episode showed no visible P waves or a short RP tachycardia were more likely to have SVT induced, but those with a long RP tachycardia were not.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^117AykiN]. Circulation (2016). Medium credibility.

Supraventricular tachycardia (SVT) of unknown mechanism — ongoing management (primary recommendations): I B-R oral beta blockers, diltiazem, or verapamil is useful for ongoing management in patients with symptomatic SVT who do not have ventricular pre-excitation during sinus rhythm; I B-NR electrophysiological (EP) study with the option of ablation is useful for the diagnosis and potential treatment of SVT; I C-LD patients with SVT should be educated on how to perform vagal maneuvers for ongoing management of SVT; IIa B-R flecainide or propafenone is reasonable for ongoing management in patients without structural heart disease or ischemic heart disease who have symptomatic SVT and are not candidates for, or prefer not to undergo, catheter ablation.

---

### Effectiveness of the valsalva manoeuvre for reversion of supraventricular tachycardia [^111wNUX3]. The Cochrane Database of Systematic Reviews (2013). Low credibility.

Background

Patients with the cardiac arrhythmia supraventricular tachycardia (SVT) frequently present to clinicians in the prehospital and emergency medicine settings. Restoring sinus rhythm by terminating the SVT involves increasing the refractoriness of AV nodal tissue within the myocardium by means of vagal manoeuvres, pharmacological agents or electrical cardioversion. A commonly used first-line technique to restore the normal sinus rhythm (reversion) is the Valsalva Manoeuvre (VM). This is a non-invasive means of increasing myocardial refractoriness by increasing intrathoracic pressure for a brief period, thus stimulating baroreceptor activity in the aortic arch and carotid bodies, resulting in increased parasympathetic (vagus nerve) tone.

Objectives

To assess the evidence of effectiveness of the Valsalva Manoeuvre in terminating supraventricular tachycardia.

Search Methods

We electronically searched the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library (Issue 1 of 12, 2012); MEDLINE Ovid (1946 to January 2012); EMBASE Ovid (1947 to January 2012); Web of Science (1970 to 27 January 2012); and BIOSIS Previews (1969 to 27 January 2012). Trials registries, the Index to Theses and the bibliographies of all relevant publications identified by these strategies were also checked.

Selection Criteria

We included all randomised controlled trials (RCTs) that examined the effectiveness of the Valsalva Manoeuvre in terminating SVT.

Data Collection and Analysis

Two authors independently extracted the data using a standardised form. Each trial was assessed for internal validity with differences resolved by discussion. Data were then extracted and entered into Review Manager 5.1 (RevMan).

Main Results

We identified three randomised controlled trials including 316 participants. All three studies compared the effectiveness of VM in reverting SVT with that of other vagal manoeuvres in a cross-over design. Two studies induced SVT within a controlled laboratory environment. Participants had ceased all medications prior to engaging in these studies. The third study reported on patients presenting to a hospital emergency department with an episode of SVT. These patients were not controlled for medications or other factors prior to intervention. The two laboratory studies demonstrated reversion rates of 45.9% and 54.3%, whilst the clinical study demonstrated reversion success of 19.4%. This discrepancy may be due to methodological differences between studies, the effect of induced SVT versus spontaneous episodic SVT, and participant factors such as medications and comorbidities. We were unable to assess any of these factors further, nor adverse effects, since they were either not described in enough detail or not reported at all. Statistical pooling was not possible due to heterogeneity between the included studies.

Authors' Conclusions

We did not find sufficient evidence to support or refute the effectiveness of the Valsalva Manoeuvre for termination of SVT. Further research is needed and this should include a standardised approach to performance technique and methodology.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^1135RKYn]. Heart Rhythm (2016). Medium credibility.

Sinus node reentrant tachycardia — an uncommon focal atrial tachycardia — is characterized by paroxysmal episodes with rates generally 100 bpm to 150 bpm, and confirmation of the reentrant mechanism requires an electrophysiology study with induction during programmed stimulation, demonstration of entrainment, and localization to the sinus node region; if the diagnosis is uncertain clinically, vagal maneuvers may be attempted to better identify the mechanism of supraventricular tachycardia.

---

### 2023 HRS expert consensus statement on the management of arrhythmias during pregnancy [^116TB7iA]. Heart Rhythm (2023). High credibility.

Vagal maneuvers for acute SVT in pregnancy — technique and precautions: Vagal maneuvers, such as the Valsalva maneuver or carotid sinus massage, are simple methods for terminating SVT and are safe to attempt in pregnant patients before pharmacological therapy; the Valsalva maneuver requires bearing down against a closed glottis for 10 to 30 seconds and is performed with the patient in a supine position; carotid massage is performed by applying pressure over the right or left carotid sinus for 5 to 10 seconds, with carotid auscultation for bruits done prior to massage; ice-cold wet towels on the face or facial immersion in cold water are alternative vagal maneuvers, and applying pressure to the eyeball has been abandoned due to risk of complications.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^1142q9dQ]. Heart Rhythm (2016). Medium credibility.

Supraventricular tachycardia (SVT) in pregnancy — acute treatment recommendations are that vagal maneuvers are recommended for acute treatment in pregnant patients with SVT, adenosine is recommended for acute treatment in pregnant patients with SVT, and synchronized cardioversion is recommended for acute treatment in pregnant patients with hemodynamically unstable SVT when pharmacological therapy is ineffective or contraindicated.

---

### 2012 ACCF / AHA / HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American college of cardiology foundation / American Heart Association task force on practice guidelines [^114T3VkK]. Journal of the American College of Cardiology (2012). Medium credibility.

Hypersensitive carotid sinus syndrome and neurocardiogenic syncope — definitions, diagnostic thresholds, and clinical considerations are outlined. The hypersensitive carotid sinus syndrome is defined as syncope or presyncope resulting from an extreme reflex response to carotid sinus stimulation, and there are 2 components of the reflex; cardioinhibitory and vasodepressor. Before concluding that permanent pacing is clinically indicated, the physician should determine the relative contribution of the 2 components of carotid sinus stimulation to the individual patient's symptom complex. Hyperactive response to carotid sinus stimulation is defined as asystole due to either sinus arrest or AV block of more than 3 seconds, a substantial symptomatic decrease in systolic blood pressure, or both, whereas pauses up to 3 seconds during carotid sinus massage are considered to be within normal limits. Because 10% to 20% of patients may have an important vasodepressive component, attention to this component is essential for effective therapy in patients undergoing pacing. Carotid sinus hypersensitivity should be considered in elderly patients who have had otherwise unexplained falls; in one study of 175 elderly patients with pauses of more than 3 seconds during carotid sinus massage randomized to pacing or nonpacing therapy, the paced group had a significantly lower likelihood of subsequent falling episodes during follow-up. Neurocardiogenic syncope accounts for an estimated 10% to 40% of syncope episodes.

---

### 2017 ACC / AHA / HRS guideline for the evaluation and management of patients with syncope: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^116NevSf]. Circulation (2017). Medium credibility.

Syncope definitions (Table 2) — vasovagal syncope (VVS), carotid sinus syndrome, situational syncope, and postural (orthostatic) tachycardia syndrome (POTS): VVS is the most common form of reflex syncope mediated by the vasovagal reflex. Carotid sinus hypersensitivity is present when a pause ≥ 3 s and/or a decrease of systolic pressure ≥ 50 mm Hg occurs upon stimulation of the carotid sinus. POTS is characterized by an increase in heart rate of ≥ 30 bpm during a positional change from supine to standing or ≥ 40 bpm in those 12–19 y of age, with the absence of OH (≥ 20 mmHg reduction in systolic BP), and the standing heart rate is often ≥ 120 bpm. Situational syncope is associated with a specific action, such as coughing, laughing, swallowing, micturition, or defecation.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^114BcCth]. Circulation (2016). Medium credibility.

Regarding nonpharmacologic interventions for atrioventricular nodal reentrant tachycardia, more specifically with respect to vagal maneuvers, ACC/AHA/HRS 2016 guidelines recommend to perform vagal maneuvers for acute management of patients with AVNRT.

---

### Part 9: adult advanced life support: 2025 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care [^114jdrZd]. Circulation (2025). High credibility.

Regarding medical management for cardiac arrest, more specifically with respect to management of narrow-complex tachycardia, pharmacotherapy, AHA 2025 guidelines recommend to administer adenosine for acute treatment of patients with regular narrow-complex tachycardias.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^1166tCys]. Heart Rhythm (2016). Medium credibility.

Orthodromic atrioventricular reentrant tachycardia (AVRT) electrocardiogram — P waves are inscribed in the ST-segment after the QRS complex, and the circuit conducts anterograde over the atrioventricular node with retrograde conduction over an accessory pathway, resulting in a retrograde P wave with short RP interval.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^114m4gYd]. Circulation (2016). Medium credibility.

Regarding nonpharmacologic interventions for supraventricular tachyarrhythmias, more specifically with respect to vagal maneuvers, ACC/AHA/HRS 2016 guidelines recommend to perform vagal maneuvers for acute management of patients with regular SVT.

---

### 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope [^115ZCxss]. Heart Rhythm (2015). Medium credibility.

Heart Rhythm Society consensus recommendation classes and evidence levels — the consensus recommendations use "class I, IIa, IIb, and III" classifications; Class I "is a strong recommendation, denoting benefit greatly exceeding risk"; Class IIa "is a somewhat weaker recommendation, denoting benefit probably exceeding risk", class IIb "denotes benefit equivalent or possibly exceeding risk", and Class III "is a recommendation against a specific treatment, because either there is no net benefit or there is net harm". Evidence levels are defined such that "Level A denotes the highest level of evidence, usually from multiple clinical trials with or without registries", "Level B evidence is of a moderate level, either from randomized trials (B-R) or well-executed nonrandomized trials (B-NR)", and "Level C evidence is from weaker studies with significant limitations, and level E is simply a consensus opinion in the absence of credible published evidence". Consensus voting for this document achieved that "The final minimum consensus was 76% and the mean was 94%".

---

### The reverse vagal manoeuvre: a new tool for treatment of supraventricular tachycardia? [^112z7q2D]. The American Journal of Emergency Medicine (2021). Medium credibility.

Supraventricular tachycardia is a common cardiac arrhytmia with recurrent episodes. The rapid resolution of supraventricular tachycardia remains a challenge. Vagal manoeuvres are simple and non-invasive but yield positive results in less than half the cases. Currently, the modified Valsalva manoeuvre appears to be the most effective technique. We have tested the effectiveness of the reverse Valsalva manoeuvre without swallowing as new vagal manoeuvre for the treatment of supraventricular tachycardia. This new technique is easy to perform and can be carried out alone by the patient. We report in this series 11 cases of supraventricular tachycardia, 10 of which were effectively reduced after the completion of the reverse Valsava manoeuvre. The very encouraging results of this series of cases will have to be quickly evaluated by a randomised controlled trial. This new technique, which is simple to learn and carry out, could be easily taught throughout the world, including in regions with few health-care resources.

---

### Vagal response varies with valsalva maneuver technique: a repeated-measures clinical trial in healthy subjects [^1146QayH]. Annals of Emergency Medicine (2004). Low credibility.

Study Objective

Variable success rates of the Valsalva maneuver in treatment of paroxysmal supraventricular tachycardia may be due to variations in performance technique. This study aimed to compare the magnitude of the vagal reflexes initiated by 5 variations of the Valsalva maneuver technique (supine, supine with epigastric pressure, supine with leg raise, semirecumbent position, and sitting position).

Methods

This was a single-blinded, repeated-measures, clinical trial of 65 subjects in sinus rhythm. Subjects performed each Valsalva maneuver technique 5 times in random order. The means of the longest ECG R-R intervals during the relaxation phase (postmaneuver R-R interval) and the postmaneuver pulse rates for each technique were compared. The mean differences between the pre- and postmaneuver R-R intervals for each technique were also compared.

Results

The supine with epigastric pressure and supine techniques resulted in longer mean postmaneuver R-R intervals (1.082 seconds [95% confidence interval (CI) 1.045 to 1.119 seconds] and 1.075 seconds [95% CI 1.035 to 1.114 seconds], respectively) than the leg raise, semirecumbent, and sitting position techniques (1.053 seconds [95% CI 1.019 to 1.086 seconds], 1.044 seconds [95% CI 1.006 to 1.081 seconds], and 1.024 seconds [95% CI 0.990 to 1.059 seconds], respectively), which equates to slower mean postmaneuver pulse rates for the supine with epigastric pressure and supine techniques (55.5 and 55.8 beats/min, respectively) than the leg raise, semirecumbent, and sitting position techniques (57.0, 57.5, and 58.6 beats/min, respectively). The supine with epigastric pressure and supine techniques also resulted in the largest premaneuver versus postmaneuver differences.

Conclusion

For healthy subjects in sinus rhythm, the supine with epigastric pressure and supine techniques generated stronger vagal responses, as measured by R-R intervals and pulse rates, than the other techniques examined. However, the vagal responses of these 2 techniques were similar, and the addition of epigastric pressure may confer little advantage.

---

### Five criteria predict induction and ablation of supraventricular tachycardia [^115Le7FG]. Journal of Cardiovascular Electrophysiology (2025). Medium credibility.

Table 2 lists the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for each of the individual features calculated over the total population. Termination with adenosine and a typical SVT EKG had the highest sensitivity and PPV (85%–95%). Termination with vagal stimulation had a high PPV (85%) but a low NPV (21%), reflecting the fact that vagal stimulation is often insufficient to terminate SVT. A monitored event lasting ≥ 30 s had a moderate PPV and NPV (76% and 49%), reflecting the sporadic nature of SVT events. Pre‐excitation was highly predictive of an ablation being performed, but only modestly predictive of SVT induction.

Table 2
Statistical parameters.

We generated a point‐based score system for estimating the preoperative probability that SVT will be induced or ablated (Figure 6B). The score reflects the relative predictive strength of each feature. Patients with any score ≥ 3 (i.e. any individual feature except pre‐excitation) have a probability of SVT induction and ablation of at least 60%. Other scoring systems based on patient questionnaires agree that those who report documentation of tachycardia, termination with medications or vagal maneuvers, or longer symptomatic episodes are more likely to have SVT induced.

In many respects our findings corroborate what would be expected from clinical intuition. One common thread is that longer duration tachycardia episodes predict successful SVT induction and ablation. We found that the cutoff duration of a monitored episode that best distinguishes inducible from noninducible patients is 30 s (Figure 4D). Some of other positively predictive features also reflect longer duration episodes. For example, to have a 12 lead EKG taken during SVT or to be given adenosine, the patient's tachycardia would have to last long enough for them to seek medical attention and undergo at least a rudimentary evaluation.

Termination of tachycardia by adenosine strongly suggests that the arrhythmia is a form of SVT that uses the AV node as part of the circuit, such as AVNRT or AVRT. Adenosine also suppresses triggered activity and can terminate the majority of FATs, many of which have a triggered mechanism. Adenosine causes only transient slowing of other common narrow complex tachycardias such as sinus tachycardia, AF, or AFL. Vagus nerve stimulation also slows AV conduction and suppresses triggered activity, but not to the same extent as adenosine.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^114xf1Rt]. Circulation (2016). Medium credibility.

Regarding nonpharmacologic interventions for orthodromic atrioventricular reentrant tachycardia, more specifically with respect to vagal maneuvers, ACC/AHA/HRS 2016 guidelines recommend to perform vagal maneuvers for acute management of patients with orthodromic AVRT.

---

### ACC / AHA / ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology / American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [^11521MEx]. Circulation (2006). Medium credibility.

Atrial fibrillation — definition and electrocardiogram (ECG) characteristics — is a supraventricular tachyarrhythmia characterized by uncoordinated atrial activation with consequent deterioration of atrial mechanical function. On the ECG, AF is characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in amplitude, shape, and timing, associated with an irregular, frequently rapid ventricular response when atrioventricular (AV) conduction is intact, and regular cardiac cycles (R-R intervals) are possible in the presence of AV block or ventricular or AV junctional tachycardia. The ventricular response to AF depends on electrophysiologically (EP) properties of the AV node and other conducting tissues, the level of vagal and sympathetic tone, the presence or absence of accessory conduction pathways, and the action of drugs, and in patients with implanted pacemakers, diagnosis of AF may require temporary inhibition of the pacemaker to expose atrial fibrillatory activity. A rapid, irregular, sustained, wide-QRS-complex tachycardia strongly suggests AF with conduction over an accessory pathway or AF with underlying bundle-branch block, and extremely rapid rates (over 200 beats per minute) suggest the presence of an accessory pathway or ventricular tachycardia.

---

### Nasocardiac reflex-induced resolution of persistent hiccups via intranasal swab stimulation: a case report [^1148RcZg]. The American Journal of Emergency Medicine (2025). Medium credibility.

Hiccups are a common respiratory reflex experienced by most individuals at some point in their lives and are typically self-limiting. In emergency department treatment, vagal maneuvers are usually the first-line approach; if unsuccessful, pharmacologic therapies are considered. We present a case of persistent hiccups successfully resolved through vagal stimulation induced by the nasocardiac reflex following nasopharyngeal stimulation with an intranasal swab. A 31-year-old female presented to the emergency department with a 72-h history of hiccups. Prior to arrival, she had attempted various vagal maneuvers without relief. Nasopharyngeal stimulation was performed via the right nostril using a polymerase chain reaction (PCR) swab. The hiccups ceased approximately five seconds into the procedure. Additionally, the patient experienced a 28% decrease in heart rate and a 22% reduction in systolic blood pressure compared to pre-procedure values. The patient was contacted by phone at 48 h, and no recurrence was reported. Although various vagal maneuvers are utilized in the management of hiccups, the role of the nasocardiac reflex has not been clearly defined. Nasopharyngeal stimulation using a PCR swab may offer a simple and safe alternative for patients with persistent hiccups. This approach also raises the possibility that PCR-induced nasocardiac reflex stimulation could serve as an alternative method in other conditions where vagal maneuvers are used, such as supraventricular tachycardia. Moreover, this method may reduce patient discomfort and potentially decrease emergency department visits.

---

### 2017 ACC / AHA / HRS guideline for the evaluation and management of patients with syncope: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^115D3ppH]. Heart Rhythm (2017). Medium credibility.

Reflex and other etiologies of syncope — definitions and key features — are outlined as: Reflex (neurally mediated) syncope is "syncope due to a reflex that causes vasodilation, bradycardia, or both"; vasovagal syncope (VVS) is "the most common form of reflex syncope" and "may occur with upright posture… or with exposure to emotional stress, pain, or medical settings", is "characterized by diaphoresis, warmth, nausea, and pallor", is "associated with vasodepressor hypotension and/or inappropriate bradycardia", and is "often followed by fatigue", with diagnosis primarily by history, exam, and eyewitness observation; carotid sinus syndrome is "reflex syncope associated with carotid sinus hypersensitivity", with hypersensitivity present when "a pause ≥ 3 s and/or a decrease of systolic pressure ≥ 50 mm Hg occurs upon stimulation of the carotid sinus"; situational syncope is "reflex syncope associated with a specific action, such as coughing, laughing, swallowing, micturition, or defecation"; cardiac (cardiovascular) syncope is "caused by bradycardia, tachycardia, or hypotension due to low cardiac index, blood flow obstruction, vasodilation, or acute vascular dissection"; noncardiac syncope is "due to noncardiac causes, which include reflex syncope, OH, volume depletion, dehydration, and blood loss".

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^1124u1iY]. Heart Rhythm (2016). Medium credibility.

Shared decision making in SVT — "It is important that the patient be included in clinical decision-making processes, with consideration of his/her preferences and goals for therapy, as well as his/her unique physical, psychological, and social situation". "In selected cases, personalized, self-directed interventions can be developed in partnership with the patient, such as vagal maneuvers and 'pill-in-the-pocket' drug therapy". "Shared decision making is especially important for patients with SVT", and "SVT treatment can be nuanced and requires expert knowledge of EP processes and treatment options". Options "are highly specific to the exact type of arrhythmia and can depend on certain characteristics of a particular arrhythmia (eg, whether there is pre-excitation)", so "a detailed explanation of the benefits and risks must be included in the conversation", with patients "encouraged to ask questions" and clinicians using "lay terminology" to provide "the best possible understanding of all management options in terms of risks, benefits, and potential effects on quality of life".

---

### 2018 ACC / AHA / HRS guideline on the Evaluation and management of Patients with bradycardia and cardiac Conduction delay: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^117UWKKC]. Journal of the American College of Cardiology (2019). High credibility.

Bradycardia or conduction disorders — history and physical examination: In patients with suspected bradycardia or conduction disorders a comprehensive history and physical examination should be performed (Class I, Level of Evidence C-EO). The history should include the frequency, timing, duration, severity, longevity, circumstances, triggers and alleviating factors of symptoms suspicious for bradycardia or conduction disorders, and because some medications can elicit or exacerbate bradyarrhythmias, a thorough review of both prescription and over-the-counter medications is essential. Carotid sinus massage can be helpful in patients with symptoms suggestive of carotid sinus hypersensitivity syndrome, but it should be performed in both the supine and upright position with careful blood pressure and electrocardiographic monitoring, and careful carotid auscultation (and/or carotid ultrasound) to exclude an ipsilateral carotid bruit is mandatory before performing this maneuver as strokes precipitated by carotid sinus massage have been reported.

---

### Common types of supraventricular tachycardia: diagnosis and management [^115P2TML]. American Family Physician (2023). Medium credibility.

Supraventricular tachycardia (SVT) is an abnormal rapid cardiac rhythm that involves atrial or atrioventricular node tissue from the His bundle or above. Paroxysmal SVT, a subset of supraventricular dysrhythmias, has three common types: atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia, and atrial tachycardia. Presenting symptoms may include altered consciousness, chest pressure or discomfort, dyspnea, fatigue, lightheadedness, or palpitations. Diagnostic evaluation may be performed in the outpatient setting and includes a comprehensive history and physical examination, electrocardiography, and laboratory workup. Extended cardiac monitoring with a Holter monitor or event recorder may be needed to confirm the diagnosis. Acute management of paroxysmal SVT is similar across the various types and is best completed in the emergency department or hospital setting. In patients who are hemodynamically unstable, synchronized cardioversion is first-line management. In those who are hemodynamically stable, vagal maneuvers are first-line management, followed by stepwise medication management if ineffective. Beta blockers and/or calcium channel blockers may be used acutely or for long-term suppressive therapy. When evaluating patients for paroxysmal SVTs, clinicians should have a low threshold for referral to a cardiologist for electrophysiologic study and appropriate intervention such as ablation. Clinicians should use a patient-centered approach when formulating a long-term management plan for atrioventricular nodal reentrant tachycardia. Catheter ablation has a high success rate and is recommended as the first-line method for long-term management of recurrent, symptomatic paroxysmal SVT, including Wolff-Parkinson-White syndrome.

---

### Vagus nerve stimulation for cardiovascular diseases: is there light at the end of the tunnel? [^114XeLvB]. Trends in Cardiovascular Medicine (2024). Medium credibility.

Autonomic dysfunction and chronic inflammation contribute to the pathogenesis and progression of several cardiovascular diseases (CVD), such as heart failure with preserved ejection fraction, atherosclerotic CVD, pulmonary arterial hypertension, and atrial fibrillation. The vagus nerve provides parasympathetic innervation to the heart, vessels, and lungs, and is also implicated in the neural control of inflammation through a neuroimmune pathway involving the spleen. Stimulation of the vagus nerve (VNS) can in principle restore autonomic balance and suppress inflammation, with potential therapeutic benefits in these diseases. Although VNS ameliorated CVD in several animal models, early human studies have demonstrated variable efficacy. The purpose of this review is to discuss the rationale behind the use of VNS in the treatment of CVD, to critically review animal and human studies of VNS in CVD, and to propose possible means to overcome the challenges in the clinical translation of VNS in CVD.

---

### 2019 ESC guidelines for the management of patients with supraventricular tachycardiaThe task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) [^112yvdtN]. European Heart Journal (2020). High credibility.

Regarding nonpharmacologic interventions for atrioventricular nodal reentrant tachycardia, more specifically with respect to vagal maneuvers, ESC 2020 guidelines recommend to perform vagal maneuvers, preferably in the supine position with leg elevation, for acute management of hemodynamically stable patients with AVNRT.

---

### 2019 ESC guidelines for the management of patients with supraventricular tachycardiaThe task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) [^115LdxeZ]. European Heart Journal (2020). High credibility.

Regarding nonpharmacologic interventions for orthodromic atrioventricular reentrant tachycardia, more specifically with respect to vagal maneuvers, ESC 2020 guidelines recommend to perform vagal maneuvers, preferably in the supine position with leg elevation, for acute management of hemodynamically stable patients with orthodromic AVRT.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^1116DFG3]. Circulation (2016). Medium credibility.

Shared decision making in supraventricular tachycardia: "It is important that the patient be included in clinical decision-making processes, with consideration of his/her preferences and goals for therapy, as well as his/her unique physical, psychological, and social situation". In selected cases, "personalized, self-directed interventions can be developed in partnership with the patient, such as vagal maneuvers and 'pill-in-the-pocket' drug therapy". "Shared decision making is especially important for patients with SVT".

---

### Electrophysiologic diagnosis of narrow and wide complex tachyarrhythmias [^1159NEjp]. Heart Rhythm (2024). Medium credibility.

Establishing the precise mechanism of cardiac arrhythmias in the electrophysiology laboratory is one of the main requisites for a successful and safe ablation. This article provides an organized approach to the differential diagnosis of narrow and wide complex tachycardias based on the analysis of electrical activation patterns, followed by specific pacing maneuvers in each case.

---

### 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope [^116VUDmA]. Heart Rhythm (2015). Medium credibility.

Hyperadrenergic POTS subtype — This manifestation occurs in up to 50% of patients and is associated with systolic blood pressure increases of ≥ 10 mm Hg while standing upright for 10 minutes and plasma norepinephrine levels ≥ 600 pg/mL while standing; patients tend to have prominent sympathetic activation symptoms and are hypersensitive to isoproterenol with tachycardic responses to doses that do not induce hemodynamic changes in healthy individuals.

---

### Initial evaluation and management of wide-complex tachycardia: a simplified and practical approach [^114EjykT]. The American Journal of Emergency Medicine (2019). Medium credibility.

The evaluation and treatment of wide QRS-complex tachycardia remains a challenge, and mismanagement is quite common. Diagnostic aids such as wide-complex tachycardia algorithms perform poorly in the real-life setting. The purpose of this review is to offer a simple clinical-electrocardiographic approach for the initial evaluation and management of the adult patient with stable wide-complex tachycardia that does not require recollection of complex guidelines or algorithms.

---

### Catheter stimulation of cardiac parasympathetic nerves in humans: a novel approach to the cardiac autonomic nervous system [^114e4PPU]. Circulation (2001). Low credibility.

Background

Cardiac parasympathetic nerves run alongside the superior vena cava (SVC) and accumulate particularly epicardially adjacent to the orifice of the coronary sinus (CS). In animals, these nerves can be electrically stimulated inside the SVC or CS, which results in negative chronotropic/dromotropic effects and negative inotropic effects in the atria but not the ventricles. Parasympathetic nerve stimulation (PS) with 20 Hz in the CS, however, also excites the atria, thereby inducing atrial fibrillation. The present study overcomes this limitation by applying high-frequency nerve stimuli within the atrial refractory period. Using this technique, we investigated for the first time whether neurophysiological effects similar to those in animals can be obtained in humans.

Methods and Results

In 25 patients, parasympathetic nerves were stimulated via a multipolar electrode catheter placed in the SVC (stimulation with 20 Hz; n = 14) or CS (pulsed 200-Hz stimuli; n = 11). A significant sinus rate decrease and prolongation of the antegrade Wenckebach period was achieved during PS in the SVC. During PS in the CS, a graded-response prolongation of the antegrade Wenckebach interval was observed with increasing PS voltage until third-degree AV block occurred in 8 of 11 patients. The negative chronotropic/dromotropic effects started and terminated immediately after the onset and termination of PS, respectively. Atropine abolished these effects (n = 11).

Conclusions

Human parasympathetic efferent nerve stimulation induces reversible negative chronotropic and dromotropic effects. PS may serve as an adjunctive tool for the diagnosis/treatment of supraventricular tachycardias and may be beneficial for ventricular rate slowing during tachycardic atrial fibrillation in patients with congestive heart failure.

---

### Neuromodulation of the failing heart: lost in translation? [^115zSRG1]. JACC: Basic to Translational Science (2016). Low credibility.

Afferent versus efferent stimulation

As noted, VNS is accomplished by placing an electrode cuff around the right or left cervical vagus, resulting in stimulation of both efferent and afferent fibers of the vagus nerve. The device and stimulation protocols used in the NECTAR-HF and ANTHEM-HF trials were designed to stimulate afferent vagus nerve fibers, whereas the device and stimulation protocol uses in the CardioFit pilot trial and INOVATE-HF trial were designed, in theory, to stimulate efferent vagus nerve fibers. From a conceptual standpoint, it may be more advantageous to stimulate afferent vagus nerve fibers, insofar as stimulation of the afferent vagus nerve fibers has been shown experimentally to decrease sympathetic efferent nerve fiber activity to the heart, which is believed to be beneficial based on a wealth of experimental and clinical observations. Moreover, the majority of the preganglionic vagal fibers terminate in small ganglia located on the posterior surfaces of the atrium, whereas far fewer ganglia reside in ventricular tissue, raising the question of whether direct stimulation of efferent vagus nerve fibers is beneficial. However, it bears emphasizing that it is currently unknown whether stimulating afferent vagus nerves, efferent vagus nerves, or a combination of afferent and efferent vagus nerves is more beneficial in the setting of HF. Similar types of difficult questions can be raised about SCS, where electrode placement can lead to inhibition of SNS trafficking to the heart and/or in increased parasympathetic tone in the heart. Thus, there are a number of important questions about how to target device-based autonomic modulatory strategies.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^115D5CfF]. Heart Rhythm (2016). Medium credibility.

Recommendations for acute treatment of SVT of unknown mechanism — vagal maneuvers are recommended for acute treatment in patients with regular SVT (COR I; LOE B-R). Vagal maneuvers, including Valsalva and carotid sinus massage, can be performed quickly and should be the first-line intervention to terminate SVT; these maneuvers should be performed with the patient in the supine position. For Valsalva, the patient raises intrathoracic pressure for 10 to 30 seconds, equivalent to at least 30 mm Hg to 40 mm Hg; carotid massage is applied for 5 to 10 seconds after confirming absence of bruit. Facial immersion in water at 10°C (50°F) has proved effective, and in one study involving 148 patients with SVT switching between techniques resulted in an overall success rate of 27.7%. The practice of applying pressure to the eyeball is potentially dangerous and has been abandoned.

---

### 2018 ACC / AHA / HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^116MWUq6]. Heart Rhythm (2019). High credibility.

ACC/AHA/HRS bradycardia — history and physical examination: In patients with suspected bradycardia or conduction disorders a comprehensive history and physical examination should be performed (Class I, Level of Evidence C-EO). The history and physical examination remains the foundation for the medical evaluation and should include the frequency, timing, duration, severity, longevity, circumstances, triggers and alleviating factors of symptoms, with attention to their relationship to medications and a thorough review of both prescription and over-the-counter medications. Carotid sinus massage can be helpful in patients with symptoms suggestive of carotid sinus hypersensitivity syndrome, but it should be performed in both the supine and upright position in a safe environment with careful blood pressure and electrocardiographic monitoring, and careful carotid auscultation (and/or carotid ultrasound) to exclude an ipsilateral carotid bruit is mandatory before performing this maneuver as strokes precipitated by carotid sinus massage have been reported.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^114rxCCp]. Circulation (2016). Medium credibility.

Narrow QRS tachycardia differential framework and RP interval definition are specified for adult evaluation: the figure addresses narrow QRS tachycardia (QRS duration < 120 ms); RP refers to the interval from the onset of surface QRS to the onset of visible P wave, with the 90‑ms interval defined from the surface ECG and the 70‑ms ventriculoatrial interval used for intracardiac diagnosis; patients with junctional tachycardia may mimic the pattern of slow‑fast AVNRT and may show AV dissociation and/or marked irregularity in the junctional rate; abbreviations include AV indicates atrioventricular; AVNRT, atrioventricular nodal reentrant tachycardia; AVRT, atrioventricular reentrant tachycardia; ECG, electrocardiogram; MAT, multifocal atrial tachycardia; and PJRT, permanent form of junctional reentrant tachycardia.

---

### Vagal termination of ventricular tachycardia in a pediatric patient [^112Udu11]. Pediatrics (2018). Low credibility.

Ventricular tachycardia is a rare clinical entity in pediatric patients and typically requires chemical and/or electrical intervention to convert into a sustained sinus rhythm. However, for certain forms originating from the right ventricular outflow tract, conversion with adenosine and vagal maneuvers has been demonstrated in adult patients. In this case, we suggest that pediatric patients with right ventricular outflow tract ventricular tachycardia who are hemodynamically stable may benefit from a trial of vagal maneuvers.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^116p4Kt7]. Circulation (2016). Medium credibility.

Sinus tachyarrhythmias — definitions and inappropriate sinus tachycardia (IST) diagnostic features: "In normal individuals, the sinus rate at rest is generally between 50 bpm and 90 bpm, reflecting vagal tone". "Sinus tachycardia refers to the circumstance in which the sinus rate exceeds 100 bpm". On electrocardiogram, "the P wave is upright in leads I, II, and aVF and is biphasic in lead V1". For IST, "Inappropriate sinus tachycardia (IST) is defined as sinus tachycardia that is unexplained by physiological demands", and "Patients with IST commonly show resting heart rates > 100 bpm and average rates that are > 90 bpm in a 24-hour period". The section emphasizes that "Thus, IST is a diagnosis of exclusion".

---

### The oculocardiac reflex: a review [^1178EwEj]. Clinical Ophthalmology (2021). Medium credibility.

Method of Literature Search

English and non-English reviews, case reports and clinical studies as well as related trigeminovagal reflexes and veterinary cases were sought. Online databases MEDLINE, PUBMED, National Library of Medicine were searched up through April 2021 using the following terms, "oculocardiac", "trigeminovagal", "diving response", "globe pressure", and "oculorespiratory reflex". In addition to sample size, each paper was entered into an EndNote library and an Excel database and critically assessed relative to definition of OCR, which EOM(s) were tested and quantity of tension, patient age and the presence of anticholinergic and opioid medications.

Neuroanatomy of the Oculocardiac Reflex: The oculocardiac reflex is perhaps the most famous of a group called the trigeminovagalreflexes (Figure 4). Various stimuli around the orbit can trigger including pain and pressure, however the classic form of oculocardiac reflex is elicited by extraocular muscle tension mediated through stretch or proprioceptors. The afferent arc travels through ciliary nerves as part of the first division of the trigeminal nerve through the Gasserian ganglion to the trigeminal sensory nucleus. Then, for reasons for which I have no teleological explanation, an immediate impulse is transmitted through the visceral motor nucleus of the vagus nerve resulting in various degrees of cardiac slowing, and bradydysrhythmias such as loss of p-waves and premature ventricular beats. A different trigemino-vagal reflex is the diving reflex, initiated best by apneic, cold facial immersion that results in profound peripheral vasoconstriction followed by a substantial bradycardia. The diving reflex helps keep diving animals alive and is less consistently demonstrated in humans. It has not been clear whether the oculocardiac reflex shares the peripheral vasoconstriction and maintained central blood pressure with its trigeminovagal "cousin", the diving response.

Figure 4
Neuroanatomy of the oculocardiac reflex. Trigeminal nerve afferents including extraocular muscle proprioceptors travel from the first division of the trigeminal nerve to be processed in the brain stem with efferent the cardiac vagus nerve.

---

### Five criteria predict induction and ablation of supraventricular tachycardia [^111Ubj6t]. Journal of Cardiovascular Electrophysiology (2025). Medium credibility.

3.3 Response to Adenosine or Vagal Maneuvers

Patients whose tachycardia terminated with adenosine were more likely to have SVT induced at EPS than other patients (Figure 3B, Table 1B). Patients whose tachycardia did not respond to adenosine showed a nonsignificant trend towards being less likely to have SVT induced.

Figure 3
Preoperative factors predicting SVT induction and ablation. Patients who exhibited each feature were compared to all patients who did not, including those with no data, except as noted below. The RR values, 95% confidence limits, and p values were calculated using Poisson regression. Asympt, Asymptomatic; CI, Confidence Interval, Excl, Excluding; RR, Risk Ratio; Sxx, Symptoms; Sympt, Symptomatic; Term, Termination. (A) An EKG showing regular and uninterrupted SVT predicts SVT induction. (B) Termination with adenosine or vagal stimulation predicts SVT induction. ND, No Data. (C) Regular SVT episodes on monitoring predict SVT induction. Patients exhibiting each feature were compared to patients who had no episodes on monitoring. (D) Pre‐excitation predicts SVT induction after other variables are excluded. (+) factor indicates typical SVT EKG, termination with adenosine or vagal stimulation, or monitored event ≥ 30 s. Note change in scale. (E) Preoperative factors that do not independently predict SVT induction. (+) factor indicates typical SVT EKG, termination with adenosine or vagal stimulation, monitored event ≥ 30 s, or pre‐excitation. (F) Negative predictive factors are non‐informative. (G) Features that predict SVT induction also predict SVT ablation. (H–I) The same features predict SVT induction and ablation in both the derivation and validation cohorts.

---

### Novel vagal maneuver technique for termination of supraventricular tachycardias [^112KQUdH]. The American Journal of Emergency Medicine (2016). Low credibility.

Hemodynamically unstable patients with supraventricular tachycardias (SVTs) should be treated with electrical cardioversion. If the patient is stable, acute termination of tachycardia can be achieved by vagal maneuvers or medical therapy. The Valsalva maneuver, carotid massage, and ice to the face are the most common vagal maneuvers. In our experience with patients, we observed that vagal stimulation increases with lying backward. Our suggested maneuver is based on quickly lying backward, from a seated position. Then, a short and powerful vagal stimulation occurs. Thus, SVT episodes can be terminated. Here we present our experience of a new maneuver for terminating SVT, with cases.

---

### Etripamil nasal spray for recurrent paroxysmal supraventricular tachycardia conversion: results from the NODE-303 open-label study [^113kT12P]. Journal of Cardiovascular Electrophysiology (2025). Medium credibility.

1 Introduction

Paroxysmal supraventricular tachycardia (PSVT) often results in significant symptoms and can have a negative impact on physical, social, and psychological aspects of health‐related quality of life. In addition, PSVT is associated with significant healthcare resource utilization, including urgent care and emergency‐department visits. Prevalence of symptomatic PSVT in the United States is ~333 per 100,000 persons, with higher rates in female patients.

Vagal maneuvers are not consistently successful in terminating PSVT, and despite modified techniques, their effectiveness can remain low. When vagal maneuvers are ineffective, sustained PSVT episodes require treatment with intravenous (IV) medications such as adenosine, beta‐blockers or calcium channel blockers (CCB) to restore sinus rhythm. Although effective, these therapies must be administered by medical personnel. Orally administered CCBs, ß‐blockers. and other antiarrhythmic drugs may be administered as a pill‐in‐pocket approach but have delayed onset of action, low success rates, and can be associated with serious adverse effects. Chronic use of oral medications for PSVT prophylaxis has inconsistent success and may be associated with adverse effects.

---

### 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death [^112Bu33B]. European Heart Journal (2022). High credibility.

Regarding medical management for ventricular arrhythmias, more specifically with respect to management of sustained VT, ESC 2022 guidelines recommend to consider administering adenosine or performing vagal maneuvres in patients presenting with regular, hemodynamically tolerated wide QRS complex tachycardia suspected for SVT.

---

### Guidelines for the diagnosis and management of syncope (version 2009) [^113r4Js5]. European Heart Journal (2009). Medium credibility.

Reflex syncope (neurally mediated syncope) — definition and subtypes — is described as a heterogeneous reflex response to triggers causing vasodilatation and/or bradycardia with a fall in arterial blood pressure (BP) and cerebral perfusion; it is classified by efferent pathway (sympathetic or parasympathetic) into vasodepressor, cardioinhibitory, or mixed types, and may also be classified by trigger (afferent pathway). Clinical forms include vasovagal syncope (VVS) mediated by emotion or orthostatic stress with typical autonomic prodromes, situational syncope tied to specific circumstances, carotid sinus syncope that in its common form is diagnosed by carotid sinus massage (CSM), and an 'atypical form' where triggers are uncertain or absent.

---

### Quinidine sulfate tablet (Quinidine sulfate) [^113igdHg]. FDA (2023). Medium credibility.

Vagolysis

Because quinidine opposes the atrial and A-V nodal effects of vagal stimulation, physical or pharmacological vagal maneuvers undertaken to terminate paroxysmal supraventricular tachycardia may be ineffective in patients receiving quinidine.

---

### P-wave amplitude and PR changes in patients with inappropriate sinus tachycardia: findings supportive of a central mechanism [^113ihma3]. Journal of the American Heart Association (2018). Low credibility.

The syndrome of inappropriate sinus tachycardia (IST) is defined as a sinus heart rate (HR) > 100 beats per minute (bpm) at rest not caused by primary causes and is associated with symptoms of palpitations, fatigue, and poor exercise tolerance. 1 Patients with IST frequently have a mean 24‐hour HR > 90 bpm during Holter monitoring with large increases in HR following minimal exertion, emotional stress, or isoproterenol infusion. The mechanisms of IST are not completely understood but are thought to be caused by either extrinsic causes (increased sympathetic activity, decreased parasympathetic activity, impaired neurohumoral modulation) or intrinsic causes (increased sinus node automaticity or β‐adrenergic hypersensitivity). 2, 3

The normal behavior of the sinus node with increased sympathetic drive is a gradual increase in HR associated with an increase in P‐wave amplitude in the inferior leads as the impulse travels superiorly along the cristae terminalis (CT). 4 The increase in sympathetic drive also results in shortening of the PR interval because of enhanced atrioventricular nodal conduction. The opposite is seen during focal atrial tachycardia (AT) where, regardless of the site of origin, the P‐wave amplitude remains unchanged at different rates, and the PR interval is prolonged relative to the PR interval during sinus rhythm because of the decremental conduction properties of the atrioventricular node. Furthermore, in patients with preserved left ventricular function, AT rates < 160 bpm often result in an increase in cardiac output and blood pressure, leading to a reflex decrease in sympathetic activity and further slowing of atrioventricular nodal conduction. 5

The purpose of this study was to assess the changes in P‐wave amplitude and PR interval in a group of patients with IST when compared with (1) a control group of patients following the administration of isoproterenol and (2) a group of patients with focal AT originating from the CT. If the mechanism of IST is extrinsic, one would expect the changes in P‐wave amplitude and PR interval to mirror what is seen in healthy controls following isoproterenol infusion (ie, increase in P‐wave amplitude in the inferior leads and shortening in the PR interval). If the mechanism of IST is intrinsic because of a focal increase in automaticity, one would expect to see no significant changes in P‐wave amplitude and PR lengthening at faster rates, similar to what is seen in patients with focal AT.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^117DRXt4]. Circulation (2016). Medium credibility.

Supraventricular tachycardia (SVT) of unknown mechanism — acute treatment: I B-R vagal maneuvers are recommended for acute treatment in patients with regular SVT; I B-R adenosine is recommended for acute treatment in patients with regular SVT; I B-NR synchronized cardioversion is recommended for acute treatment in patients with hemodynamically unstable SVT when vagal maneuvers or adenosine are ineffective or not feasible and is recommended for acute treatment in patients with hemodynamically stable SVT when pharmacological therapy is ineffective or contraindicated; IIa B-R intravenous diltiazem or verapamil can be effective for acute treatment in patients with hemodynamically stable SVT; IIa C-LD intravenous beta blockers are reasonable for acute treatment in patients with hemodynamically stable SVT.

---

### 2019 ESC guidelines for the management of patients with supraventricular tachycardiaThe task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) [^114QgpYr]. European Heart Journal (2020). High credibility.

Regarding nonpharmacologic interventions for supraventricular tachyarrhythmias, more specifically with respect to vagal maneuvers, ESC 2020 guidelines recommend to perform vagal maneuvers for acute management of hemodynamically stable patients with wide QRS tachycardia in the absence of an established diagnosis.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^116ts1pK]. Circulation (2016). Medium credibility.

Regarding specific circumstances for supraventricular tachyarrhythmias, more specifically with respect to pregnant patients, acute management, ACC/AHA/HRS 2016 guidelines recommend to perform vagal maneuvers for acute management of pregnant patients with SVT.

---

### Diagnosis and management of paroxysmal supraventricular tachycardia [^116VGhWU]. JAMA (2024). Excellent credibility.

Importance

Paroxysmal supraventricular tachycardia (PSVT), defined as tachyarrhythmias that originate from or conduct through the atria or atrioventricular node with abrupt onset, affects 168 to 332 per 100 000 individuals. Untreated PSVT is associated with adverse outcomes including high symptom burden and tachycardia-mediated cardiomyopathy.

Observations

Approximately 50% of patients with PSVT are aged 45 to 64 years and 67.5% are female. Most common symptoms include palpitations (86%), chest discomfort (47%), and dyspnea (38%). Patients may rarely develop tachycardia-mediated cardiomyopathy (1%) due to PSVT. Diagnosis is made on electrocardiogram during an arrhythmic event or using ambulatory monitoring. First-line acute therapy for hemodynamically stable patients includes vagal maneuvers such as the modified Valsalva maneuver (43% effective) and intravenous adenosine (91% effective). Emergent cardioversion is recommended for patients who are hemodynamically unstable. Catheter ablation is safe, highly effective, and recommended as first-line therapy to prevent recurrence of PSVT. Meta-analysis of observational studies shows single catheter ablation procedure success rates of 94.3% to 98.5%. Evidence is limited for the effectiveness of long-term pharmacotherapy to prevent PSVT. Nonetheless, guidelines recommend therapies including calcium channel blockers, β-blockers, and antiarrhythmic agents as management options.

Conclusion and Relevance

Paroxysmal SVT affects both adult and pediatric populations and is generally a benign condition. Catheter ablation is the most effective therapy to prevent recurrent PSVT. Pharmacotherapy is an important component of acute and long-term management of PSVT.

---

### Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient [^116jhZ6p]. Critical Care Medicine (2016). Medium credibility.

Regarding follow-up and surveillance for cardiac arrest, more specifically with respect to post-resuscitation care (neuromuscular blockade), SCCM 2016 guidelines recommend to obtain peripheral nerve stimulation, if obtained, in conjunction with assessment of other clinical findings (triggering of the ventilator and degree of shivering) to assess the degree of neuromuscular blockade in patients undergoing therapeutic hypothermia.

---

### Five criteria predict induction and ablation of supraventricular tachycardia [^111WXERt]. Journal of Cardiovascular Electrophysiology (2025). Medium credibility.

In other respects our findings run counter to clinical intuition. The frequency of SVT events on monitoring is poorly correlated with induction, probably because the number of sustained episodes is overwhelmed by a high background of short bursts of atrial tachycardia. Patients who report more frequent symptoms are more likely to have SVT induced, so if short bursts were screened out such a correlation might exist. Sudden onset of symptoms does not by itself predict successful induction or ablation of SVT, nor does a history of syncope. The mode of presentation (ER, clinic, or incidental) makes no difference. Failure of an arrhythmia to terminate with adenosine or vagal stimulation carries less information than termination. In such cases the arrhythmia mechanism may not have been of a type that would respond, or the effect of the intervention may have been insufficient to cause termination.

Perhaps most importantly, our findings identify a group of patients in whom induction or ablation of SVT is unlikely and in whom EPS could be avoided. These patients characteristically have shorter recorded episodes of SVT. Patients with shorter bursts of SVT would be more likely to have the initiation or termination captured on a 12 lead EKG, which we find suggests non‐induction. A second characteristic of non‐inducible patients is an irregular tachycardia. Irregularity was associated with short duration episodes; about 2/3 of the irregular tachycardias recorded on an EKG started or stopped while the EKG was being recorded and vice‐versa. Additionally, irregular episodes of tachycardia captured on monitoring tended to be shorter than regular episodes (Figure 4B). Irregularity suggests that the tachycardia mechanism is non‐reentrant FAT, either because of variable AV block or because the tachycardia focus itself fires irregularly (Figure 2 I‐J). Patients with an irregular SVT noted pre‐operatively were more likely to have FAT diagnosed at EPS than the total population (not shown). Nevertheless, ~85% of preoperative recordings from patients diagnosed with FAT showed a regular SVT.

---

### 2015 ACC / AHA / HRS guideline for the management of adult patients with supraventricular tachycardia: executive summary: a report of the American college of cardiology / American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society [^112PRmGD]. Circulation (2016). Medium credibility.

Acute treatment of regular supraventricular tachycardia (SVT) of unknown mechanism — algorithm: Initiate "Vagal maneuvers and/or IV adenosine (Class I)". If "ineffective or not feasible", assess if the patient is "Hemodynamically stable". If not stable, perform "Synchronized cardioversion* (Class I)". If stable, administer "IV beta blockers, IV diltiazem, or IV verapamil (Class IIa)", and if these are "ineffective or not feasible", proceed to "Synchronized cardioversion* (Class I)". The figure notes, "For rhythms that break or recur spontaneously, synchronized cardioversion is not appropriate", and clarifies that IV indicates intravenous.

---

### 2018 ESC guidelines for the diagnosis and management of syncope [^111nFouq]. European Heart Journal (2018). Medium credibility.

Regarding diagnostic investigations for syncope, more specifically with respect to autonomic function tests (Valsalva maneuver), ESC 2018 guidelines recommend to consider performing the Valsalva maneuver to assess autonomic function in patients with suspected neurogenic orthostatic hypotension.

---

### Five criteria predict induction and ablation of supraventricular tachycardia [^114WM9cj]. Journal of Cardiovascular Electrophysiology (2025). Medium credibility.

ABSTRACT

Introduction

Current guidelines recommend electrophysiological study (EPS) and ablation for primary treatment of supraventricular tachycardia (SVT), but there is little information to guide patient selection for the procedure. The purpose of this study was to identify preoperative features that would predict whether patients with signs or symptoms of tachycardia were likely to have SVT induced and ablated at EPS.

Methods

We performed a retrospective chart review of 1089 patients referred for EPS and ablation of SVT at 2 high volume centers. The population consisted of a derivation cohort of 810 patients and a validation cohort of 279 patients. We evaluated various clinical, EKG, and monitor features to determine which ones correlated with SVT induction or ablation.

Results

Five preoperative findings predicted a high probability that SVT would be induced and ablated at EPS:
1 A characteristic EKG recording of SVT.
2 Termination of SVT with adenosine.
3 Termination of SVT or symptoms with vagal maneuvers.
4 An episode of SVT lasting ≥ 30 s on a monitor recording.
5 Pre‐excitation on the baseline EKG.

Patients exhibiting at least one of these features had a high probability of SVT induction and ablation, while those exhibiting none had a low probability (Induction, 76% vs. 19%, RR = 3.96 (2.76–5.69), p < .001; Ablation, 88% versus 26%, RR = 3.32 (2.48–4.46), p < .001). A point‐based score was derived and validated that can be used to estimate the probability of induction and ablation for individual patients.

Conclusion

Simple criteria classify patients as having a high or low probability of SVT induction and ablation at EPS. They can be used as a guide for clinical decision making when considering invasive testing for patients with symptoms of tachycardia.